TOL3010B
Drug
TOLMAR, INC.
Total Payments
$1.0M
Transactions
245
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $1.0M | 245 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.0M | 245 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TOL3010B | TOLMAR, INC. | $1.0M | 0 |
Top Doctors Receiving Payments for TOL3010B
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Anaheim, CA | $1.0M | 245 |
Ad
Manufacturing Companies
- TOLMAR, INC. $1.0M
Product Information
- Type Drug
- Total Payments $1.0M
- Total Doctors 0
- Transactions 245
About TOL3010B
TOL3010B is a drug associated with $1.0M in payments to 0 healthcare providers, recorded across 245 transactions in the CMS Open Payments database. The primary manufacturer is TOLMAR, INC..
Payment data is available from 2018 to 2018. In 2018, $1.0M was paid across 245 transactions to 0 doctors.
The most common payment nature for TOL3010B is "Unspecified" ($1.0M, 100.0% of total).
TOL3010B is associated with 1 research study, including "TOL3010B" ($1.0M).